DOD transfer awards

Active Cooperative Agreement Awarded Last action

Award ID
IDSEP240074
Recipient
Awarding agency
Obligated
$61,822,336

Award facts

Completion date 19% complete
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA) Biodefense Medical Countermeasure Development program (CFDA 93.360), has awarded a $61,822,336.47 cooperative agreement to Endo USA, Inc. The award, effective September 12, 2024 through November 30, 2035, supports the development of medical countermeasures such as vaccines, therapeutics, diagnostics, and devices to address biological, chemical, radiological, and nuclear threats, as well as pandemic influenza and emerging infectious diseases. Endo USA, Inc., a for-profit pharmaceutical manufacturer, will leverage this funding to advance research and production capabilities for critical medical products that can mitigate public health emergencies and strengthen national health security.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $20,607,445
Amendment $20,607,445
Original award $20,607,445

Quick answers

Who received award IDSEP240074?

IDSEP240074 was awarded to Endo Usa, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 12, 2024.

How much is award IDSEP240074 worth?

$61,822,336 has been obligated on IDSEP240074.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award